Melatonin administration does not affect isoproterenol-induced LVH

IEEE Engineering in Medicine and Biology Magazine

Volumn 25, Issue 3, 2006, Pages 84-87

  Flood, Elizabeth M ^b   Kumar, Robert S ^b   Shah, Rashmi ^b   Amos, Quinlan ^b   Wren, Jonathan D ^b   Shohet, Ralph V ^b   Garner, Harold R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISOPRENALINE; MELANIN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART VOLUME; HYPERTENSION; INFORMATION PROCESSING; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; STATISTICAL ANALYSIS;

ANIMALS; DIAGNOSIS, COMPUTER-ASSISTED; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; ISOPROTERENOL; MALE; MEDLINE; MELATONIN; MICE; SOFTWARE;

EID: 33746123846     PISSN: 07395175     EISSN: None     Source Type: Journal    
DOI: 10.1109/MEMB.2006.1636358     Document Type: Article

References (31)

1. L.L. Tin, D.G. Beevers, and G.Y. Lip, "Hypertension, left ventricular hypertrophy, and sudden death," Curr. Cardiol Rep., vol. 4, pp. 449-457, 2002.
2. J. Diez, A. Gonzalez, B. Lopez, S. Ravassa, and M.A. Fortuno, "Effects of antihypertensive agents on the left ventricle: Clinical implications," Am. J. Cardiovasc. Drugs, vol. 1, pp. 263-279, 2001.
3. F.H. Messerli, "Hypertension and sudden cardiac death," Am. J. Hypertens., vol. 12, pp. 181S-188S, 1999.
4. J.D. Wren and H.R. Garner, "Shared relationship analysis: Ranking set cohesion and commonalities within a literature-derived relationship network," Bioinformatics, vol. 20, pp. 191-198, 2004.
5. J.D. Wren, R. Bekeredjian, J.A. Stewart, R.V. Shohet, and H.R. Garner, "Knowledge discovery by automated identification and ranking of implicit relationships," Bioinformatics, vol. 20, pp. 389-398, 2004.
6. R.Y. Moore, "Circadian rhythms: Basic neurobiology and clinical applications," Annu. Rev. Med., vol. 48, pp. 253-266, 1997.
7. H. Girouard, C. Chulak, M. LeJossec, D. Lamontagne, and J. de Champlain, "Chronic antioxidant treatment improves sympathetic functions and beta-adrenergic pathway in the spontaneously hypertensive rats," J. Hypertens, vol. 21, pp. 179-188, 2003.
8. F.A.J.L. Scheer, G.A. Van Montfrans, E.J.W. van Someren, G. Mairuhu, and R.M. Buijs, "Daily night-time melatonin reduces blood pressure in male patients with essential hypertension," Hypertension, vol. 43, pp. 192-197, 2004.
9. D.J. Duncker and P.D. Verdouw, "Has melatonin a future as a cardioprotective agent?," Cardiovasc. Drugs Ther., vol. 15, pp. 205-207, 2001.
10. Z. Chen, C.C. Chua, J. Gao, R.C. Hamdy, and B.H. Chua, "Protective effect of melatonin on myocardial infarction," Am. J. Physiol. Heart Circ. Physiol., vol. 284, pp. H1618-H1624, 2003.
11. M. Jonas, D. Garfinkel, N. Zisapel, M. Laudon, and E. Grossman, "Impaired nocturnal melatonin secretion in non-dipper hypertensive patients," Blood Press, vol. 12, pp. 19-24, 2003.
12. C.M. Blatt, S.H. Rabinowitz, and B. Lown, "Central serotonergic agents raise the repetitive extrasystole threshold of the vulnerable period of the canine ventricular myocardium," Circ. Res., vol. 44, pp. 723-730, 1979.
13. M.F. Xu, S. Ho, Z.M. Qian, and P.L. Tang, "Melatonin protects against cardiac toxicity of doxorubicin in rat," J. Pineal. Res., vol. 31, pp. 301-307, 2001.
14. A. Kladna, H.Y. Aboul-Enein, and I. Kruk, "Enhancing effect of melatonin on chemilumines" cence accompanying decomposition of hydrogen peroxide in the presence of copper," Free Radic. Biol. Med., vol. 34, pp. 1544-1554, 2003.
15. S. Bertuglia, P.L. Marchiafava, and A. Colantuoni, "Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation, " Cardiovasc. Res., vol. 31, pp. 947-952, 1996.
16. G. Fowler, M. Daroszewska, and K.U. Ingold, "Melatonin does not 'directly scavenge hydrogen peroxide': Demise of another myth," Free Radic. Biol. Med., vol. 34, pp. 77-83, 2003.
17. M.O. Boluyt, X. Long, T. Eschenhagen, U. Mende, W. Schmitz, M.T. Crow, and E.G. Lakatta, "Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart," Am. J. Physiol., vol. 269, pp. H638-H647, 1995.
18. M. Kuschel, Y.Y. Zhou, H.A. Spurgeon, S. Bartel, P. Karczewski, S.J. Zhang, E.G. Krause, E.G. Lakatta, and R.P. Xiao, "β2-adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart," Circulation, vol. 99, pp. 2458-2465, 1999.
19. H. Enzminger, K. Witte, and B. Lemmer, "Altered melatonin production in TGR(mREN2)27 rats: On the regulation by adrenergic agonists, antagonists and angiotensin II in cultured pinealocytes," J. Pineal. Res., vol. 31, pp. 256-263, 2001.
20. E. Zalatan, J.A. Krause, and D.E. Blask, "Inhibition of isoproterenol-induced lipolysis in rat inguinal adipocytes in vitro by physiological melatonin via a receptor-mediated mechanism," Endocrinology, vol. 142, pp. 3783-3790, 2001.
21. D.L. Wang, Z.Q. Ling, F.Y. Cao, L.Q. Zhu, and J.Z. Wang, "Melatonin attenuates isoproterenol-induced protein kinase A overactivation and tau hyperphosphorylation in rat brain," J. Pineal. Res., vol. 37, pp. 11-16, 2004.
22. C. Ekmekcioglu, T. Thalhammer, S. Humpeler, M.R. Mehrabi, H.D. Glogar, T. Holzenbein, O. Markovic, V.J. Leibetseder, G. Strauss-Blasche, and W. Marktl, "The melatonin receptor subtype MT2 is present in the human cardiovascular system," J. Pineal. Res., vol. 35, pp. 40-44, 2003.
23. L. Naji, A. Carrillo-Vico, J.M. Guerrero, and J.R. Calvo, "Expression of membrane and nuclear melatonin receptors in mouse peripheral organs," Life Sci., vol. 74, pp. 2227-2236, 2004.
24. E. Soto-Vega, I. Meza, G. Ramirez-Rodriguez, and G. Benitez-King, "Melatonin stimulates calmodulin phosphorylation by protein kinase C," J. Pineal. Res., vol. 37, pp. 98-106, 2004.
25. J.D. Molkentin, J.R. Lu, C.L. Antos, B. Markham, J. Richardson, J. Robbins, S.R. Grant, and E.N. Olson, "A calcineurin-dependent transcriptional pathway for cardiac hypertrophy," Cell., vol. 93, pp. 215-228, 1998.
26. N. Frey and E.N. Olson, "Cardiac hypertrophy: The good, the bad, and the ugly," Annu. Rev. Physiol., vol. 65. pp. 45-79, 2003.
27. T.P. Andersson, H.N. Skold, and S.P. Svensson, "Phosphoinositide 3-kinase is involved in Xenopus and Labrus melanophore aggregation," Cell. Signal, vol. 3, no. 15, pp. 1119-1127, 2003.
28. G.F. Anhe, L.C. Caperuto, M. Pereira-Da-Silva, L.C. Souza, AE. Hirata, L.A. Velloso, J. Cipolla-Neto, and C.R. Carvalho, "In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus," J. Neurochem, vol. 90, pp. 559-566, 2004.
29. S.V. Naga Prasad, G. Esposito, L. Mao, W.J. Koch, and H.A. Rockman, "Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy," J. Biol. Chem., vol. 275, pp. 4693-4698, 2000.
30. M.H. Soonpaa and L.J. Field, "Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice," Am. J. Physiol., vol. 266, pp. H1439-H1445, 1994.
31. A. Cavallo and M. Hassan, "Stability of melatonin in aqueous solution," J. Pineal. Res., vol. 18, pp. 90-92, 1995.